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Abstract
Background: To achieve good clinical outcomes with HAART, patient adherence to treatment
and care is a key factor. Since the literature on how to care for pediatric HIV patients is limited,
we describe here adherence interventions implemented in our comprehensive care program in a
resource-limited setting in Kenya.
Methods: We based our program on factors reported to influence adherence to HIV care and
treatment. We describe, in detail, our program with respect to how we adapted our clinical
settings, implemented psycho-social support activities for children and their caregivers and
developed treatment literacy for children and teenagers living with HIV/AIDS.
Results: This paper focused on the details of the program, with the treatment outcomes as
secondary. However, our program appeared to have been effective; for 648 children under 15
years of age who were started on HAART, the Kaplan-Meier mortality survival estimate was
95.27% (95%CI 93.16–96.74) at 12 months after the time of initiation of HAART.
Conclusion: Our model of pediatric HIV/AIDS care, focused on a child-centered approach with
inclusion of caregivers and extended family, addressed the main factors influencing treatment
adherence. It appeared to produce good results and is replicable in resource-limited settings.
Background
While the overall prevalence of Human Immunodefi-
ciency Virus (HIV) infection in Kenya was reported to
have declined to 5.1% in 2006, an estimated 102,000
children under 15 years of age were living with HIV, of
whom about 6000 received highly active antiretroviral
therapy (HAART).[1,2] In resource limited settings,
HAART has produced good results in the treatment of HIV
Published: 21 November 2008
BMC Pediatrics 2008, 8:52 doi:10.1186/1471-2431-8-52
Received: 28 March 2008
Accepted: 21 November 2008
This article is available from: http://www.biomedcentral.com/1471-2431/8/52
© 2008 Van Winghem et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.BMC Pediatrics 2008, 8:52 http://www.biomedcentral.com/1471-2431/8/52
Page 2 of 13
(page number not for citation purposes)
in children.[3-7] In Kenya, increased access to free HIV-
rapid testing, PCR testing and, since June 2006, free
HAART, has reduced mortality among children living with
HIV.[2]
To achieve good clinical outcomes from HAART, patient
adherence to treatment and care is a key feature. [8]
Adherence is also important to reduce the risk of develop-
ment of drug resistant strains of HIV.[8] For children liv-
ing with HIV, a number of studies have emphasized the
importance of patient and caregiver psychosocial support
to optimise adherence to treatment and care. [9-13] Chil-
dren are vulnerable and feel stress differently from adults.
For instance, they are often dependent on caregivers,
orphaned or have lost at least one parent.[2,14] Many live
in foster families, and there are difficulties with disclosure
of their HIV-positive status. Children living with HIV
often report experiencing discrimination in school,
church, the community or family, and they have fears of
the future. [14,15]
Predictors of adherence to treatment and care
Factors that predict problems with adherence to treatment
include patient related factors, medication factors, the
relationship between the patient and health care provider,
and the system of care. [8] We discuss briefly the first
three. Patient related factors include patient resources,
knowledge, attitudes, beliefs, perceptions, expectations
and psychosocial issues, all of which influence behaviour,
the critical link between treatment and outcome. [8]
Adherence can also be influenced by socioeconomic cir-
cumstances that may lead to a situation of having to
choose between competing priorities, paying the trans-
port fee to go to the clinic or buying food for the family.
[8] Medication related factors include the complexity of
the medical regimen, the dosage and duration of treat-
ment, side effects, and availability of medical support and
patient education. [8] The quality of the relationship
between patient and health care provider in the manage-
ment of a chronic disease such as HIV is important to
ensure effective communication, continuity of care, confi-
dence and trust so that they are seen as partners in care
and not as authoritarian figures. [8,13]
Adherence is a dynamic and complex process that is influ-
enced by the interplay of these and other factors. [8] For
children living with HIV, strategies to optimise adherence
to HIV treatment and care require regular review and
adaptation based on the individual needs and growth of a
child. [16,17] Interventions to optimise treatment adher-
ence among children living with HIV, such as psychoso-
cial support activities, have seldom been described in
detail in the literature, so they can be reproduced. We
describe here in detail adherence interventions in our
pediatric HIV comprehensive care program in a resource-
limited setting.
The setting of our pediatric HIV/AIDS care program
Since 1997 MSF-Belgium has been providing care and
treatment for people living with HIV/AIDS in Nairobi,
Kenya, in collaboration with the Ministry of Health
(MOH). The program has provided free HIV care and
treatment to outpatients at the only public district hospi-
tal in Nairobi Province and to patients at three clinics in
the informal settlement of Kibera. The comprehensive
care package included counselling and testing, manage-
ment of opportunistic infections, HAART assessment and
treatment (since 2003), psychosocial support, nutritional
support and treatment literacy training. In two of the Kib-
era clinics HIV and tuberculosis (TB) care were integrated
into comprehensive primary health care services. MSFB
has also conducted a range of training and health promo-
tion activities for patients, local communities and health
care workers, to increase the capacity of these groups to
better understand and manage HIV/AIDS.
To summarise the profile of our pediatric cohort, as of 30
November 2007, 1205 HIV-infected and HAART-naive
children under 15 years of age had been enrolled in our
HIV program, 657 (55%) of whom were initiated on
HAART (Table 1). Of the 657 children initiated on
HAART, 452 (69%) were still on HAART and in active care
on 30 November 2007 (attended at least one appoint-
ment since 1 August 2007). Kaplan-Meier survival meth-
ods were used to estimate the probability of survival from
the time of initiation of HAART to death. Date of death
was taken as the endpoint for those patients who died. A
patient was considered lost to follow up if they were not
confirmed dead, had not been transferred out, and had
not attended the clinic in the four months prior to the
date of analysis (no clinic attendance on or since 1 August
2007). Patients lost to follow up were censored at the time
of last appointment to a clinic. Patients transferred out to
another service provider were censored at the time of
transfer. All other patients were censored at the time of
last clinic visit up to 30 November 2007. Analysis was
conducted in STATA version 8.2 (StataCorp, 4905 Lake-
way Drive College Station, Texas, 77845, USA). The Kap-
lan-Meier mortality survival estimate at 12 months was
95.3% (95%CI 93.2–96.7) and at 24 months was 94.3%
(95%CI 91.9–96.1) (Figure 1). This is comparable to mor-
tality survival estimates reported among a pediatric
HAART cohort from South Africa. [4]
Through our experience of operating a pediatric HAART
program in a resource-limited setting with a high HIV
prevalence, we noticed that the psychological impact of
HIV on children was often overlooked. We initiallyBMC Pediatrics 2008, 8:52 http://www.biomedcentral.com/1471-2431/8/52
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Kaplan-Meier survival curve of children placed on Highly Active Anti-Retroviral Treatment in Nairobi, Kenya Figure 1
Kaplan-Meier survival curve of children placed on Highly Active Anti-Retroviral Treatment in Nairobi, Kenya.
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observed a high loss to follow up in our pediatric HAART
cohort. In response to these challenges and to scale up and
strengthen our program we adopted a more a holistic
approach to the management of child and teenage
patients. An important feature has been the constant
adaptation over time of our program, based on the needs
of patients and experience in the field.
Adaptation of the system of care
In 2005 a multidisciplinary working group comprising cli-
nicians, counsellors, social workers, and health promo-
tion officers identified, along the medical care pathway
from testing to treatment and follow up, critical points
where predictors of adherence for children and teenagers
could be potentially addressed. Our aim was to strengthen
the adherence of children to treatment and care, as well as
to scale up testing and enrolment of HIV-infected children
into the program. The medical care pathway and treat-
ments for children living with HIV in our program were
systematised and in accordance with the World Health
Organization (WHO) and Kenyan National Guidelines,
and updated as required.[18,19]
Critical points along the medical care pathway where 
predictors of adherence could be addressed
1. HIV testing and disclosure of the results to a child
In our project the disclosure of the HIV positive status of
a child by a caregiver was a major challenge, and became
a focal point for psychosocial support to both parties. The
absence of disclosure has been reported as a risk factor for
non-adherence, and we observed this is in our program.
[9,13]
We emphasized the family approach, by asking for each
adult patient, at every visit, about their child's health and
HIV status. For each child testing HIV positive, we pro-
posed that siblings and parents be tested. Families were
given appointments for the same day as much as possible.
Table 1: Characteristics of Antiretroviral-naïve children (1 January 2003 – 30 November 2007)
Characteristics Number (%)
Number ever enrolled in HIV care 1205
Sex
- Female 638 (53.0%)
Age at time of enrolment
- < 3 years 398 (33.0%)
- 3 – 5 years 371 (30.8%)
- 6 – 8 years 231 (19.2%)
- 9 – 14 years 205 (17.0%)
- Median age in years (IQRa) 4.88 (2.0–7.8)
Length of time in program (years)
- Average 1.28
- Median 0.95
- IQR 0.2–2.1
Number initiated on HAARTb 657 (54.5%)
Age when started HAART
- < 3 years 147 (22.4%)
- 3 – 5 years 204 (31.1%)
- 6 – 8 years 153 (23.3%)
- 9 – 14 years 153 (23.3%)
- Median age in years (IQR) 5.50 (3.2–8.7)
Sex of patients placed on HAART
- Female 327 (49.8%)
Length of time on HAART (years)
- Average 1.47
- Median 1.36
- IQR 0.6–2.2
Outcomes of patients on HAART on 30 November 2007: 657
- On treatment and followed 452 (68.8%)
- Dead 32 (4.9%)
- Transferred out 106 (16.1%)
- Lost to follow up (did not attend clinics since 1 August 07) 67 (10.2%)
Number switched to second line therapy 7 (1.1%)
a. Interquartile range
b. Highly Active Anti-Retroviral TreatmentBMC Pediatrics 2008, 8:52 http://www.biomedcentral.com/1471-2431/8/52
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The actual timing of disclosure was not recorded, but
according to the counsellors in charge of the children's
and teenagers' groups, the average age where disclosure
was carried out was between 8–12 years of age with a
"best" age at 9 years. This appeared to be an appropriate
age since the child had a good understanding of the dis-
ease and that he or she had to receive treatment for life.
The timing of disclosure also depended on other factors
such as the educational background of the child, his or her
social exposure and level of understanding.
2. Patient enrolment in the clinic, HAART therapy assessment, 
preparation, adherence and follow up
The following stages of patient management were consid-
ered important to target with psychosocial activities and
other strategies to support adherence to treatment and
care.
Once a child was confirmed to be HIV-positive, a unique
patient file was opened, and the first medical examination
was conducted, including a CD4 count. If the child quali-
fied for HAART, a process of multidisciplinary assessment
was commenced: the counsellor, social worker, nutrition-
ist and medical staff assessed the patient. The multidisci-
plinary team (MDT) together with the patient and/or
caregiver developed an individual plan for preparation
and initiation of treatment.
If HAART was commenced, the child came back after two
weeks to be assessed for HAART tolerance, adherence
counselling and other psychosocial and health concerns.
Patient progress was regularly monitored with an individ-
ually-tailored appointment schedule. If there were any
concerns regarding a patient, the MDT reviewed the case
and then discussed the issues with the caregiver and the
child, to include them in the decision-making process.
We set the following goals for psychosocial support and
other activities for child and teenage patients: to help
patients to cope better with their HIV status and disease,
understand and accept the necessity of life-long and
sometimes intense treatment, improve quality of life,
avoid stress and suffering, and to support the child's
growth and development. To ensure their active participa-
tion in decisions about their own health care, the child
and teenage patient were placed at the centre of the psy-
chosocial activities. The goals of psychosocial support and
other activities for caregivers (and where possible the
entire family) were to assist them to understand and
accept HIV and the need for prolonged treatment and fol-
low-up and to manage the child in the same manner as
HIV-negative siblings.
Adherence was assessed at every visit by self report, pill
count and pharmacy records. It is interesting to note from
that the patients' side that they sometimes felt as though
we didn't trust them when we kept asking about adher-
ence and counting pills. Measurement of CD4 counts
were conducted at regular intervals for each patient, and
viral load (VL) studies were performed on a case by case
basis as required (unpublished data).
Interventions to promote adherence
Based on factors influencing adherence, we implemented
a range of interventions (Table 2). The interventions can
be described along three axes: adaptation of our system of
care, psychosocial support activities and capacity building
activities.
Axis 1
First, we tailored our system of care to better meet the
needs of child and teenage patients through:
a) Creation of child-friendly clinic environments
In each clinic a special room was dedicated for children
and furnished with games, toys, videos and colourful
painted walls. At the hospital based clinic a playground
was constructed adjacent to the clinic. One day per week
was dedicated to being a pediatric clinic day. On this day
children in each clinic were gathered in the pediatric room
for group activities, led by young adult peer educators
with the help of a counsellor and sometimes a volunteer
(for example, a teacher living with HIV). During the pedi-
atric clinic day a pediatrician was available to see compli-
cated medical cases.
b) Strengthening the family approach
Family-centered care was the key theme in this program.
Adult and children were enrolled in the same clinic. When
one family member tested positive, the health staff (coun-
sellors and clinicians) took every opportunity to get other
members tested. Adult patients were usually only enrolled
if they were in WHO Clinical Stages 3 or 4 however, if they
were in Stage 1 or 2, and had a child in the clinic, they
were automatically enrolled. Whenever a child had an
appointment, the parent was seen as well; the bookings
were synchronized whenever possible.
On pediatric days, parents and caregivers were gathered in
separate groups for discussion. Parents with unknown or
negative status were grouped together and patient-parents
formed their own group. Issues were discussed such as
importance of knowing your status, disclosure of status,
and how to care for a child living with HIV, especially
when you had other children. For parents or caregivers of
unknown or HIV negative status, treatment literacy cov-
ered some basics about home-based care for positive chil-
dren as well as the usual subjects related to HAART
adherence.BMC Pediatrics 2008, 8:52 http://www.biomedcentral.com/1471-2431/8/52
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Following the Hero Book training, during which the child
creates a kind of memory book that has him function
both as the hero, the illustrator and the story teller, thus
allowing him to confront particular challenges in his life,
time was devoted for an individual meeting including the
child, a counsellor and the caregiver to go through the
book and answer any questions. This permitted the car-
egiver and counsellor to gauge how well the child under-
stood their illness.
To address social support issues, we tried to work within a
network of other non-governmental organizations to
whom we could refer families for shelter, school fees, food
support, and other social needs.
The caregivers of orphans had their own issues like feeling
unsupported and/or discouraged about caring for a child
who was not their own. They had fears about their own
children becoming infected from the orphan or the effect
of positive discrimination towards the HIV positive child
Table 2: Interventions to promote adherence to a pediatric HAART program, Nairobi
Factors predicting adherence 
to treatment and care
System adaptation Psycho-social support Capacity building
Patient-related factors Child friendly clinics with:
- Playground
- Social support network to refer 
patient to according to the needs 
and demands.
- Treatment literacy training
- A dedicated pediatric clinic day - Development of material 
(fairytale, booklet)
- Hero book training
- Pediatric waiting bay with toys, 
video, games.
- Support groups - Attitude training
- Pediatric counselling room - Individuals therapy session - Community based campaigns to 
promote awareness and 
understanding of the specific plight 
of children living with HIV/AIDS
- Testing and counselling 
decentralised in the ward with 
special session to help the coping 
with disclosure of positive status
- Financial support for bus fare
- 3 target groups: children, 
teenagers and caregivers
- Referral to Post Test Clubs
- Art therapy
- Sand therapy
- Individual counselling tailored 
schedule
Therapy related factors - Pill boxes - Treatment literacy training
- Tick sheets
- Enrolment of children born from 
a positive mother until HIV status 
is confirmed
- Malnutrition screening
- Provision of supplementary and 
therapeutic food
- Referral to a Pediatrician
Patient-provider relationship 
factors
- Childrens' Fun Day Staff training in:
- HIV medicine
- Training of young peer PLWHA 
in basic counselling and in training 
of the trainer on a range of 
curricula
- Pediatric HAART
- Basic counselling
- Attitude training
- Treatment literacy
- Counsellors trained in various 
techniques for counselling (Hero 
book, play therapy, and training of 
the trainer for treatment literacy)
- PLWHA peer counsellor trained 
in basic counselling skills, 
treatment literacy and ToT for TLBMC Pediatrics 2008, 8:52 http://www.biomedcentral.com/1471-2431/8/52
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(e.g., giving them special food, a special plate, special
attention, etc). All these issues were tackled in open meet-
ings or directly in the support groups and treatment liter-
acy sessions whose curriculum had been tailored to
address all these issues.
The orphans in custody of the grandparents presented
other challenges. Often the grandparents were illiterate
and didn't have a stable financial income (as they were
working anymore). For these caregivers, we met with
them individually, to educate them on the disease and
implications. We provided transport fees and referred
them to other partners for social support.
c) Strengthening the system for tracing patients who miss 
appointments
Every patient who missed an appointment was traced by a
phone call, home or hospital visit.
d) 'Child/teenager Fun Days'
During every school holiday period on Saturdays, groups
of about 40 children and 20 staff (including reception
staff, data entry clerks, doctors, social workers, peer educa-
tors) spent a social day out together. Teenage patients and
a limited number of caregivers also participated. The fun
days were comprised of visits to child-friendly sites (such
as a giraffe centre, animal orphanage, and fun parks),
activities (such as Olympic games, live music and danc-
ing, Christmas activities) in schools that agreed to lend us
their fields, and a shared meal. Fun days have strength-
ened the relationships between patients and staff and pro-
vided them with an opportunity to talk and socialise
outside of the clinic and have fun together. Fun days have
also given children and caregivers the chance to meet
peers and form social networks. Another important aim
was to take the children out of their daily lives just to have
fun.
e) Setting three target groups for psychosocial support and capacity-
building interventions: children, teenagers and caregivers
We set these target groups to ensure we tailored adherence
interventions to the unique needs of each group. Children
were still quite dependent and needed parenting. Teenage
patients had their own particular issues regarding the
beginning of their own sexual lives, fear of transmitting
the virus, fear of not being able to get married and have
children, feelings of depression or even suicide. Caregivers
had their own issues either due to being HIV positive
themselves or trying to integrate a HIV positive child into
their family.
f) Pillboxes and tick sheets to assist patients with taking treatment
To help the child taking their pills on time, a system of tick
sheets and pillboxes was initiated. For some children, a
watch with an alarm was provided.
Axis 2
Second, we developed and implemented a range of psy-
chosocial support activities and tools for children, teen-
agers and their caregivers, including:
a) A fairytale titled "Thanks ARVS"
The fairytale tells how germs (such as the virus causing
flu) and the HIV virus were spread in an animal village by
a wicked hyena, causing the villagers to become sick and
die. It explained how normally the magic force (immunity
cells) in their bodies could fight the germs and how HIV
weakened that magic force by using them to replicate
themselves in the body. Fortunately, Uncle Lion and Aunt
Elephant found a treatment (HAART) to stop the virus
replicating and destroying the magic force. They give
advice on how to stay healthy and on the importance of
supporting each other to adhere to treatment and to cope
with challenges, such as the bad taste of some pills that
can be hard to swallow. Developed by a counsellor in the
MSF-Belgium Thailand HIV project, this fairytale was
adapted to the Kenyan context and published in English
and Kiswahili languages [Additional file 1]. The fairytale
was used as a communication tool and was aimed at cre-
ating a positive understanding of HIV, emphasizing basic
concepts about the disease, treatment and how to main-
tain health. At the end of the book were questions about
the fairytale, but also about the reader's own story. The
fairytale helped children verbalise questions and concerns
about the story, but also to progressively relate themselves
to that story and recognise their own situation.
This tool has been used by counsellors at the stage of pre-
HAART assessment; the counsellor read through the story
with the child, the child then took the book home, and at
the second HAART-assessment counselling session, the
counsellor went through the questions to assess if the
child has understood what it was about (long term disease
and treatment, importance of taking the pills everyday,
importance of healthy and positive living). The fairytale
has also proven useful in assisting caregivers and counsel-
lors to disclose to a child their HIV-positive status,
through reading the story and answering the child's ques-
tions, for example, "Oh the giraffe is taking pills morning and
evening like me; do we have the same disease?...".
b) A booklet for teenagers titled "All you need to know about HIV 
and ARVS sYouth Booklet"
This is a pocket size booklet containing basic information
about HIV, AIDS, opportunistic infections (OIs), HAART,
nutrition and positive living attitudes, illustrated in a col-
ourful layout with drawings by a young Kenyan artist
[Additional file 2]. The drawings illustrate the fight
between Masaai warriors (CD4) and the virus. It was often
used with teenage patients in the pre-HAART assessment
counselling sessions; the counsellor went through theBMC Pediatrics 2008, 8:52 http://www.biomedcentral.com/1471-2431/8/52
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booklet with the patient, the patient then took the booklet
home, and during the second HAART assessment counsel-
ling session, the counsellor answered and asked questions
to assess the level of understanding of the youth. The
booklet was also a useful tool for participants of treatment
literacy training.
c) Individual counselling and specialised counselling techniques
Individual counselling was strengthened through the
adoption of special psychotherapy techniques. No specific
behavioural model was used, but the counsellors were
trained by the Kenyan Association of Professional Coun-
sellors (KAPC) in association with Durham University
(UK) on child counselling techniques.
Children seldom spontaneously mention their feelings,
so techniques of drawing or playing were used to facilitate
discussion. Counsellors were trained in these techniques.
Sand therapy was used as a therapeutic technique employ-
ing a sand tray, a source of water, and miniatures of peo-
ple, animals, buildings, bridges, vehicles, furniture, food,
plants and rocks, with which the child could build scenes
on the sand. Sand therapy was used to gain access to the
content of the unconscious.[20,21] The counsellor
observed the play and how a child expressed themselves
through manipulation of the miniature objects and the
creation of a diorama, without intrusion. A review of the
scene took place later with the child, and the counsellor
made notes that were retained in the patient file so that a
session to session assessment could be made of the psy-
chotherapeutic process.[20,21] Counsellor's also imple-
mented art-therapy, with drawing and clay modelling as
the medium in a similar, observational manner, during
individual counselling sessions.
These different psychotherapy techniques could be used at
any stage after a patient was enrolled in the clinic, whether
or not the child was on HAART. These techniques were
used to deal with patient concerns such as coping with
their HIV-positive status, stigma, discrimination, death of
a family member or fear of their own death. Children were
identified by the counsellors for these specific psycholog-
ical interventions through individual counselling ses-
sions, group activities (hero book, treatment literacy,
support groups) or disclosure sessions. The selection of
these children was left to the counsellor's discretion. For
example, during a Hero book session with one particular
child, while addressing the issues of family tree, the child
burst into tears while remembering his deceased father
and then was very quiet and sad for the rest of the session.
This was new information since this child had been fol-
lowed in normal sessions without this issue being raised.
This child was assessed by the counsellor to be a good can-
didate for individual counselling.
d) Support groups for children and teenage patients
Support groups for children (usually 10 to 13 years of age)
and teenagers (usually 14 to 18 years of age) were com-
menced and each comprised of up to 15 participants. Each
support group was lead by two counsellors. The decision
to join a support group was a joint one between the
patient and a counsellor.
The children's support groups were proposed by the chil-
dren themselves, following one of the treatment literacy
trainings. They felt it was important to be part of a support
group, and planned to meet monthly. Within the group
sessions children shared their experiences, especially
about stigma and discrimination in their family and at
school. The counsellors facilitated the discussion to assist
the children to talk freely without feeling ashamed or
guilty about their experiences. During support group ses-
sions, children told each other their stories, offered each
other support, and proposed solutions to cope with issues
raised, based on their own experiences. Our experience
has been that children greatly appreciate belonging to a
group and the strength and support they derive from the
group. On two occasions the children consented to the
anonymous recording and transcription of children's sto-
ries discussed in the support groups, and this material has
been used in forums to raise awareness about stigma and
discrimination experienced by children living with HIV.
The children's support group began with 15 participants
in 2007 and increased to 59 by mid-2008.
The teenager's group support was proposed by a young
counsellor who was concerned about the feelings of lone-
liness and desperation he had observed among teenage
patients. Teenage patients were enthusiastic about the
idea of a support group, and relieved to know that they
were not alone in having difficulty coping with their diag-
nosis. The teenage support group called themselves "Les
Anges de la vie" (angels of life) and utilised t-shirts bear-
ing this slogan to prompt people to ask what the slogan
meant. This gave the teenagers a chance to share their
story with others. Within the group the participants
shared stories and went on excursions to have fun with
their peers. The support group has helped to develop the
teenagers to a stage where many of them wish to be open
about their status and their experiences of stigma and dis-
crimination. The teenager support group began with 12
participants in 2007 and increased to 36 regular partici-
pants by mid-2008.
The following anecdote was reported by counsellors and
gives an indication of the potential benefits of support
groups: A teenage girl was on first line treatment but not
improving, (VL > 100,000) despite her claim that she was
taking the pills. A switch to second line treatment wasBMC Pediatrics 2008, 8:52 http://www.biomedcentral.com/1471-2431/8/52
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considered. However, when she started to talk about feel-
ing lonely and even contemplating suicide, her counsellor
encouraged her to join the support group. While attend-
ing the support group, she related in her own words how
she was in the process of accepting herself. This led to a
real improvement in her adherence and she remained on
first line regimen, since her VL had dropped to less than
600. She continued to attend every meeting of the support
group, and even brought two friends from school who
were HIV positive and received their drugs elsewhere.
e) Mini groups for caregivers
We established support (mini) groups for caregivers
which were held on each dedicated pediatric clinic day.
Mini-groups were 30 to 45 minutes in duration and took
place while caregivers waited for their child to be called
for a consultation. Mini groups comprised of about 12 to
15 caregivers (regardless of HIV status) and were led by a
peer counsellor living with HIV who had been trained in
basic counselling skills. Depending on the group
dynamic, the peer counsellor started the session by shar-
ing their personal experience as a young person living
with HIV, then opened up the discussion to the group for
questions and sharing of experiences among the group. If
the group had met in the past, the peer counsellor chose a
theme and the group discussed experiences on that theme.
Time was given at the end of each session to discuss any
other issues. Important themes included disclosure,
stigma and discrimination, nutrition and the importance
of honouring appointments.
f) Social support
Financial assistance was provided on a case-by-case basis
(for example, to meet transport costs for appointments or
cover costs of tests to be conducted outside the clinic).
Members of the MDT who identified a patient in extreme
need referred the patient to one of the social workers for
assessment. The social workers established a social sup-
port network system whereby patients with specific needs
were referred to other organisations for support as school
fees, school materials and uniforms, food, and legal
issues.
Axis 3
Third, we developed and implemented a range of capac-
ity building interventions tailored to the needs of child
and teenage patients and caregivers. These interventions
included:
a) Treatment Literacy Training
UNESCO/WHO have identified treatment education as
"...forming the bridge between the provision of treatment
and the preparation and involvement of people and com-
munities in comprehensive responses to HIV and AIDS".
[[22]. p.5] Based on this philosophy, we developed a
three-day theoretical training in treatment literacy that
was regularly updated by the MDT. The curriculum has
been tailored to meet the unique needs and capacities of
each of the target groups.
Treatment literacy training was three days in duration for
caregivers, and four, three-quarter days (8 am to 2 pm) for
child and teenage patients as their concentration was
reduced considerably after lunch. Each course consisted of
10 to 15 participants led by two counsellors. Peer counsel-
lors living with HIV and medical staff joined in for train-
ing on specific topics. An interactive approach to training
was used. Approximately 130 children and 35 caregivers
were trained in 3 years.
The aim of treatment literacy training for child and teen-
age patients was to provide knowledge and skills to under-
stand and manage (to the best of their capacities) their
disease, treatment and broader health issues, and to equip
them with tools to take some responsibility for their own
health. For caregivers, the aim was to provide knowledge
and skills to better understand the disease process in their
children and its consequences. Issues addressed included
knowledge, attitudes and beliefs towards HIV status dis-
closure, HIV and associated treatment and care, opportun-
istic infections, nutrition, home based care, and the
development of communication skills. For caregivers liv-
ing with HIV, treatment literacy training for adults was
also provided.
b) Hero book training
The 'Hero book' was a form of memory book in which the
child/teenager was the hero and the author. It included a
series of drawing exercises and autobiographic story tell-
ing. It assisted children to think about and express their
problems and challenges and to develop ways of solving
them. The Hero book was developed under the umbrella
of the 10 Million Memory Projects, a psychosocial sup-
port initiative by the Regional Psycho Social Support Ini-
tiative (REPSSI) and partners [21]. Details of Hero book
training can be found at http://web.uct.ac.za/depts/cgc/
Jonathan/index.htm. [23]
Hero book training comprised a week of group sessions
with a maximum of ten participants of a similar age. Our
first Hero book trainings were led by external artists and
counsellors. More recently, three to four of our trained
counsellors lead each Hero book training. Children did
not have to know their HIV status to attend. Costs of trans-
port, food and materials were covered.
c) Clinic-based staff training and support
Staff of all disciplines participated in training on a range
of topics including HIV medicine, pediatric HAART, atti-
tude training, treatment literacy, basic counselling andBMC Pediatrics 2008, 8:52 http://www.biomedcentral.com/1471-2431/8/52
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communication skills and advanced counselling tech-
niques. Staff were supervised and attended regular profes-
sion-based and MDT meetings. Staff who required
counselling for work related issues were referred to a con-
fidential, external counsellor who attended the clinics
once per week.
d). Increased involvement of patients and people living with HIV/
AIDS in clinic and community based activities
Four patients were trained as peer educators and counsel-
lors and integrated into the program's work force. In a
period of 3 years around 280 patients also completed
Training of the Trainer (ToT) courses in treatment literacy
and 120 in attitude training, and they have been recruited
to train others in these areas.
While many of these interventions could be introduced in
a flexible manner anywhere along the medical care path-
way, some were particularly useful at certain stages. For
instance, to target the critical point of HIV testing and dis-
closure, we utilised the Fairytale, Treatment Literacy Train-
ing for caregivers, and individual counselling sessions and
support (or mini) group sessions for caregivers. To target
the critical points along the path of patient enrolment in
the clinic, HAART assessment, preparation, adherence and
follow up, the various support activities included treat-
ment literacy for children and teenagers, Hero book train-
ing, support groups for the patient, HAART preparation
and adherence counselling and specific individual and
group counselling activities for children.
Discussion
This report describes in detail our comprehensive pro-
gram for providing HIV care and HAART to children in a
challenging, resource-limited setting. Attention to the
principles of good adherence led us to individualize care
for both child/teenage patients and their caregivers,
actively address psychosocial needs and build capacity of
children and teenagers to engage in their own treatment.
We believe that this program helped to realize good treat-
ment outcomes and that our experience would benefit
other programs in similar circumstances.
Our description illustrates how it was possible to imple-
ment a child-centred approach with full consideration of
the child/teenager as the patient-individual. In addition,
attention to the child's family was a key component in the
program. This approach is important because HIV is a
long term condition and HAART is a life long therapy
which needs to be strictly followed. From a public health
point of view maintaining adherence is the only way of
preventing drug resistance. It is also important because
children face different types of stress compared to adults.
Our program tried to deal with this issue with its flexible
approach and adapted tools. Revisiting the principles of
adherence, we believe that this program addressed most
of them in a realistic manner. Patient-related factors of
knowledge, attitudes, beliefs and fears were approached in
several ways, from education, to play groups to individual
counselling. Basic socioeconomic conditions were cared
for by social workers. Difficulties in taking medications
were managed by practical tools for pill monitoring and
education around their importance. Finally, the relation-
ships between caregivers and patients/family were
strengthened in many ways from use of peer counsellors
to fun days. We believe our good medical outcomes are
due to attention to these key issues.
We have not formally evaluated individual components
of the program. It would be difficult to assess which inter-
ventions were the most useful for the children or caregiv-
ers, as most children participate in several activities
concurrently, and the 'package' of interventions is tailored
for each individual. We acknowledge that a formal quali-
tative evaluation of individual interventions would be
very useful. There is however, continual communication
between patients, caregivers and staff that is fed back to
program coordinators, which in turn informs adaptation
of the interventions and program. For instance Counsel-
lors reported that in informal group discussions with chil-
dren, it appeared as though no specific aspects of the
program stood out as the best activity, as they considered
each aspect to be part of a whole. The children appreciated
their own clinic space and the many activities that helped
them work out their feelings or just have fun and forget
their illness. Similarly, discussions among caregivers in
the group sessions revealed problems as the program
developed and these were addressed. For example, trans-
port costs were a barrier to attending, and these were paid
for once this problem was raised. This informal iterative
loop, along with regular patient and program monitoring
activities, have been used to informally evaluate aspects of
the program.
Challenges
There were a number of challenges in implementing our
program that need to be discussed. The dependence of the
child on their caregivers meant that the child's adherence
was directly related to the willingness and ability of the
caregiver to attend. If the caregiver was not convinced
about the need for regular attendance or was unable to
accompany the child due to work or illness, adherence
suffered. If there were several caregivers, it could be diffi-
cult to communicate correctly on the treatment plan.
Hence, we made strong efforts to engage the caregivers as
key members of the treatment team.
The socio-economic situation of the family was also a
challenge, given that transport fees were double every
time the child had an appointment (child and caregiver).BMC Pediatrics 2008, 8:52 http://www.biomedcentral.com/1471-2431/8/52
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We addressed this by providing financial assistance for
transport on case-by-case basis after social assessment.
Another problem was that pediatric HIV care was still not
a priority in the HIV care program; the focus was mainly
on adults especially for the adherence counselling support
package. It was a challenge to introduce a child-centred
approach with inclusion of the caregiver and whenever
possible the entire family for care and offer psychosocial
support. Eventually, our efforts were recognized, but this
problem may be present in other contexts and needs to be
anticipated.
Practical concerns included that the size of pillboxes was
inconvenient for some regimens (DDI or syrup), and the
price of pillboxes was too high. This required additional
funding by MSF, and may be an issue of sustainability in
government funded programs.
Children were easily bored if the same material was used
over and over so that a constant review of the program's
operating plans and methods was required to avoid disin-
terest. As well, fun activities had to take place during
school leave or on weekends, creating some scheduling
difficulties. For multiple days training, caregivers had to
ask permission for leave from work, which was not always
granted.
At the structure level, there was limited physical capacity
of the clinics to cater for child-specific activities and
rooms. Rapid turn over of trained medical staff was a
major challenge. It was why we trained more young peo-
ple living with HIV in counselling and ToT, to shift the
tasks from medical staff to volunteers who would be likely
to remain long term with the program.
Ways Forward
To continue to develop the program, we plan to adapt and
diversify the range of materials, games, and posters. As
well, we hope to make an agreement with a local radio sta-
tion to have regular show with and for children/teenagers.
In order to ensure continuity and harmonisation of the
program activities, we propose having teams of two per-
sons (health promotion and counsellor) "specialised" in
pediatric counselling activities, to be responsible for the
development or adaptation of strategies and material.
Several other practical suggestions include: having a free
telephone line for patient or caregivers to ask their ques-
tions or share their concerns; train more young people liv-
ing with HIV to be counsellors to lead support groups for
children and teenagers in their community; target teachers
for treatment literacy to reduce stigma and discrimination
in the school environment; and develop alternatives to
pill boxes, (for example, pill bags made of plastic covered
with a local printed fabric).
To scale up the treatment literacy for children/teenagers
and caregivers, opening a training center was proposed.
The training curriculum would be divided into modules
that would take place once a week so the participants
could complete the curriculum at their own rhythm
according to their availability.
A formal evaluation of the psychosocial support activities
for children, teenagers and caregivers is warranted, to try
and determine which interventions are most effective in
supporting patients to adhere to care and treatment. A
patient and program monitoring system is in place and a
data management team ensures that a wide range of data
is available at routine intervals to assist with program eval-
uation. At every clinic attendance for each patient, demo-
graphic, social, clinical, biological, immunological and
laboratory data are recorded and entered into a database,
and data are cleaned, analysed and reported on monthly,
quarterly, annually and as required. Data are also col-
lected on social work, counselling activities, patient trac-
ing episodes activities, pill count, self report adherence,
and other activities. Analysis of these data will be done in
further operational research activity and will be submit for
publication.
Finally, the issue of sustainability is always present in
projects like this. The MoH needs to be convinced that
HIV care and treatment for children is a priority. Most of
the interventions described here are not expensive, based
mostly on careful organization of care and use of volun-
teers to extend the reach and capacity of the program. We
believe that demonstrating good results with low cost to a
MoH should be convincing.
Conclusion
Adherence is the key factor of success of pediatric HAART
programs and our experience of focusing on a child-cen-
tered approach with inclusion of caregivers and extended
family appears to foster this. We believe that our model is
feasible in resource-limited settings and hope the details
described here will assist other programs in similar con-
texts.
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